Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06058117Unknown

Paediatric European Group A Streptococcal United Study.

Role: collaborator

NCT05855889Recruiting

Observational Study of the Management of Infants With Congenital CMV

Role: collaborator

NCT03982732Unknown

Maternal Antibody in Milk After Vaccination

Role: collaborator

NCT00487019Completed

Management of Early Onset Neonatal Septicaemia: Selection of Optimal Antibacterial Regimen for Empiric Treatment

Role: collaborator

All 4 trials loaded